Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Open-label Study of the Effect of Etanercept on Vascular Inflammation in Patients With Active Rheumatoid Arthritis

NCT02109289 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT02109289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02109289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Open-label Study of the Effect of Etanercept on Vascular Inflammation in Patients With Active Rheumatoid Arthritis
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2014
Completion date
November 30, 2016
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis, vascular inflammation